|
| Exchange Received Time 02/11/2017 18:03:43 Exchange Disseminated Time 02/11/2017 18:03:48 Time Taken 00:00:05 | Ref.: Intimation under Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('LODR, 2015')
Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, we wish to inform you that Board has today at its meeting approved the Unaudited Financial Results for the Second Quarter and Half Year ended September 30, 2017.
The said meeting of the Board commenced at 02.00 p.m. and concluded at 5.40 p.m.
The copy of the said results together with Management Discussion & Analysis, Press Release and Limited Review Report of the Auditors is enclosed herewith.
These are also being made available on the website of the Company at www.glenmarkpharma.com.
You are requested to take the same on record.
|
|
|